VI. The benzodiazepine agonist clonazepam potentiates the effects of γ-aminobutyric acid on α-MSH release from neurointermediate lobes in vitro.

This publication has 18 references indexed in Scilit:

• In vitro study of frog (Rana ridibunda Pallas) neurointermediate lobe secretion by use of a simplified perifusion system
  General and Comparative Endocrinology, 1986
• GABA-ergic control of α-Melanocyte-Stimulating Hormone (α-MSH) release by frog neurointermediate lobe in vitro
  Brain Research Bulletin, 1986
• Neuropeptide Y in the intermediate lobe of the frog pituitary acts as an α-MSH-release inhibiting factor
  Life Sciences, 1986
• GABAergic Regulation of Melanocyte-Stimulating Hormone Secretion from the Pars Intermedia ofXenopus Laevis: Immunocytochemical and Physiological Evidence
  Endocrinology, 1986
• Characteristics of Receptors for Dopamine in the Pars intermedia of the Amphibian Xenopus laevis
  Neuroendocrinology, 1986
• Co-localization of GABAA receptors and benzodiazepine receptors in the brain shown by monoclonal antibodies
  Nature, 1985
• Analysis of benzodiazepine binding sites in rat pituitary gland
  Brain Research, 1984
• Autoradiographic localisation of benzodiazepine receptors in the rat pituitary gland
  European Journal of Pharmacology, 1984
• Catecholaminergic Control of α-Melanocyte-Stimulating Hormone (αMSH) Release by Frog Neurointermediate Lobe in Vitro: Evidence for Direct Stimulation of αMSH Release by Thyrotropin-Releasing Hormone*
  Endocrinology, 1983
• Thyrotropin-releasing hormone stimulates the release of melanotropin from frog neurointermediate lobes in vitro
  Life Sciences, 1980